Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | AXSM | ABVX | ||
| Company | Arrowhead Pharma | Axsome Thera | Abivax Sa ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 65.50 | 181.80 | 111.68 | ||
| High | 68.44 | 184.09 | 118.20 | ||
| Low | 63.46 | 178.00 | 110.47 | ||
| Latest | 64.52 | 182.55 | 117.67 | ||
| Change | -0.12 | +1.71 | +6.96 | ||
| % Change | -0.19% | +0.95% | +6.29% | ||
| Volume | 24,090,502 | 661,700 | 672,700 | ||
| 20-Day Average Volume | 3,235,015 | 705,475 | 1,386,185 | ||
| Previous Close | 64.64 | 180.84 | 110.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 67.08 | 182.24 | 117.04 | ||
| 20-Day Raw Stochastic | 19.85% | 61.07% | 45.13% | ||
| 20-Day Relative Strength | 49.57 | 59.37 | 49.81 | ||
| Weighted Alpha | +218.75 | +83.63 | +183.20 | ||
| Today's Opinion | 72% Buy | 100% Buy | 56% Buy | ||
| Previous Opinion | 72% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.94% since 01/30/26 | -0.92% since 01/30/26 | +5.87% since 01/30/26 | ||
| Low | 63.46 on 02/06/26 | 178.00 on 02/06/26 | 107.42 on 02/02/26 | ||
| High | 76.11 on 02/03/26 | 190.76 on 02/03/26 | 118.20 on 02/06/26 | ||
| 1-Month | |||||
| %Chg | -8.88% since 01/06/26 | +6.21% since 01/06/26 | -1.20% since 01/06/26 | ||
| Low | 61.65 on 01/20/26 | 165.75 on 01/08/26 | 107.42 on 02/02/26 | ||
| High | 76.11 on 02/03/26 | 191.50 on 01/22/26 | 130.13 on 01/15/26 | ||
| 3-Month | |||||
| %Chg | +62.93% since 11/06/25 | +30.94% since 11/06/25 | +13.25% since 11/06/25 | ||
| Low | 37.06 on 11/20/25 | 134.49 on 11/07/25 | 100.50 on 11/13/25 | ||
| High | 76.76 on 01/06/26 | 191.50 on 01/22/26 | 148.83 on 12/24/25 | ||
| 6-Month | |||||
| %Chg | +295.59% since 08/06/25 | +76.79% since 08/06/25 | +70.31% since 08/06/25 | ||
| Low | 15.01 on 08/08/25 | 101.88 on 08/07/25 | 67.15 on 08/20/25 | ||
| High | 76.76 on 01/06/26 | 191.50 on 01/22/26 | 148.83 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,050,311 | 9,116,685 | 8,684,535 | ||
| Shares Outstanding, K | 140,011 | 50,413 | 78,444 | ||
| Annual Sales | 829,450,000 | 385,690,000 | 0 | ||
| Annual Net Income | -1,630,000 | -287,220,000 | -190,710,000 | ||
| Last Quarter Sales | 256,470,000 | 170,990,000 | 0 | ||
| Last Quarter Net Income | -23,750,000 | -47,230,000 | -179,260,000 | ||
| 60-Month Beta | 1.21 | 0.40 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.22 on 02/05/26 | -0.94 on 11/03/25 | -2.45 on 12/15/25 | ||
| Latest Earnings Date | 02/05/26 | 02/23/26 | 03/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||